HOME >> BIOLOGY >> NEWS
Cloning reverses aging in cow cells, a milestone in medical research

agriculture," said Cristofalo, who, in addition to leading the Lankenau Institute for Medical Research, is also a professor of pathology, anatomy and cell biology at Jefferson Medical College of Thomas Jefferson University in Philadelphia. He is internationally recognized for his research on the molecular mechanisms of cellular aging.

His work is based on findings that suggest that cellular aging is characterized by differential gene expression. Furthermore, Cristofalo's studies also show that the inability of senescent cells to synthesize DNA in response to growth factors (and thus divide again) is partially based on impaired signaling pathways between the sensing sites at the cell membrane and the targets in the nucleus.

Francis is an associate investigator at the Lankenau Institute for Medical Research and often collaborates with Cristofalo. Her research examines the mechanism of action of a particular protein that declines during cellular aging. She focuses on the role that the loss of this protein has in the development of diseases that afflict the elderly, such as tumor formation, wound-healing and chronic skin conditions. Francis is also an assistant professor of pathology, anatomy and cell biology at Jefferson Medical College.

The Lankenau Institute for Medical Research is a subsidiary of Main Line Health. It is located on the campus of Lankenau Hospital, located in suburban Philadelphia, in a state-of-the-art building where investigators concentrate on molecular, cellular and developmental biology specific to cancer, atherosclerosis, heart disease, osteoporosis, Alzheimer's disease and other diseases of aging.

"The theme of aging and the diseases of aging is a rare focus for a research center. Our ultimate goal is to determine the basis for the vulnerability to these diseases as we age, and to help people stay independent and productive during their lives, while reducing the impact of age-related diseases," said Cristofalo.


'"/>

Contact: Laura Feragen
laura@toplin.com
215-886-4644
Thomas Jefferson University
25-Apr-2000


Page: 1 2

Related biology news :

1. Cloning pigs and drug discovery among hot topics
2. Cloning chip
3. Cloning primates is turning out to be a real challenge
4. Cloning can turn back the developmental clock
5. Cloning reverses aging in cow cells, Scienceauthors say
6. First Reproducible Cloning Of Mammals From Adult Cells Reported In Nature
7. Human Cloning: Grappling With Reality Penn Bioethicist To Explore The Facts Behind The Hysteria
8. The Cloning of Humans On The Adoption Model: Penn Bioethicist Will Present A Model For Future Laws Involving Human Cloning
9. UNESCO Director-General Reaffirms That Human Cloning Is Contrary To Human Dignity
10. Human Cloning: International Bioethics Committee President Stresses Political And Moral Commitment
11. Gene therapy reaches muscles throughout the body and reverses muscular dystrophy in animal model

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cloning reverses aging cow cells milestone medical research

(Date:2/5/2015)... 28, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... Global Online CEO Conference on January 29 th ... Pereira , CEO of NXT-ID will present and host ... Wocket smart wallet and its full suite of biometric ...
(Date:2/5/2015)... , Jan. 30, 2015  It is gratifying ... power and potential for genomic science as a means ... disease prevention and treatment.  I was honored to participate ... government-funded precision medicine program. Since the ... science of genomics—from the first sequenced genome of a ...
(Date:1/22/2015)... and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ) has announced the ... report to their offering. , The ... individual is who she/he is claiming to be, and for ... unique physical characteristics, such as fingerprint, hand or palm print, ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3
(Date:3/3/2015)... Experts and industry insiders from around the ... Alltech REBELation exploring innovation, inspiration and world-changing ideas in ... 31st year, Alltech’s annual international conference traditionally draws more ... to join the REBELation at an extra discount registration ... at which point the standard early registration rate will ...
(Date:3/3/2015)... 2015 /CNW/- SQI Diagnostics Inc. (TSX:V: SQD), a life sciences ... products for advanced microarray diagnostics, today announced it ... its Management team. In his capacity as CFO ... from a development stage to a commercially successful ... Company,s capital market strategy and to secure funding ...
(Date:3/3/2015)... 3, 2015  Regenicin, Inc. (OTC Bulletin Board: ... development of and commercialization of regenerative cell therapies to ... today that it has received the final payment to ... Inc. (OTC Bulletin Board: AMBS ). ... the final payments due to Regenicin in the amount ...
(Date:3/3/2015)... ROCKVILLE, Md. , March 3, 2015  RegeneRx ... an editorial in the scientific journal, Expert Opinion ... and his colleague, Dr. Zhenggang Zhang , at ... reported that Thymosin beta 4 (TB4) has ... (PNS) remodeling 24 hours or more post-injury, leading to ...
Breaking Biology Technology:World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3
Cached News: